Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| lab products division of CareDx, Inc. | Eurobio Scientific FR | Laboratory Diagnostic & Testing Substances | $22.1M – $29.9M | 7× – 9× | |
| CareDx, Inc. lab products division | Eurobio Scientific FR | Laboratory Diagnostic & Testing Substances | $135M – $160M | 12× – 14× | |
| Diagnostica Stago | ARCHIMED | Laboratory Diagnostic & Testing Substances | $512M | 15× – 17× | |
| Thermo Fisher Scientific's microbiology business | Astorg | Laboratory Diagnostic & Testing Substances | $2,700M – $3,200M | 16× – 19× | |
| Invitech Ltd. | Calibre Scientific | Laboratory Diagnostic & Testing Substances | $24.0M – $28.0M | 10× – 11× | |
| Kova International, Inc. | LGC Group | Laboratory Diagnostic & Testing Substances | $240M – $280M | 12× – 14× | |
| Apijã, Laborsys, Macromed | Viveo | Laboratory Diagnostic & Testing Substances | $15.4M | 0.4× | |
| Biogenetix | Grupo Mafra | Laboratory Diagnostic & Testing Substances | $273M – $369M | 6× – 8× | |
| Mabiotech | Best Health | Laboratory Diagnostic & Testing Substances | $18.0M – $22.0M | 7× – 8× | |
| Tulip Diagnostics | PerkinElmer | Laboratory Diagnostic & Testing Substances | $220M – $260M | 11× – 13× |
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.